These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 156039)

  • 1. In vivo behaviour of some antithrombin III-protease complexes.
    Lam LS; Regoeczi E; Hatton MW
    Br J Exp Pathol; 1979 Apr; 60(2):151-60. PubMed ID: 156039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of thrombin, plasmin, thrombin-antithrombin III complex and plasmin-antithrombin III complex with isolated hepatocytes.
    Spolarics Z; Kalapos MP; Léránt I; Garzó T; Antoni F; Mandl J; Machovich R
    Biochim Biophys Acta; 1989 Aug; 1012(3):231-6. PubMed ID: 2547438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of thrombin-antithrombin III complex to hepatocytes.
    Bauer PI; Mandl J; Machovich R; Antoni F; Garzo T; Horváth I
    Thromb Res; 1982 Dec; 28(5):595-606. PubMed ID: 6220483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated endocytosis of thrombin-antithrombin III complex by the human monocytoid cell line U937.
    Takeya H; Hamada T; Kume M; Suzuki K
    Biochem Biophys Res Commun; 1994 May; 200(3):1334-40. PubMed ID: 8185584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin.
    Essex DW; Miller A; Swiatkowska M; Feinman RD
    Biochemistry; 1999 Aug; 38(32):10398-405. PubMed ID: 10441134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin, and trypsin.
    Smith GF; Sundboom JL
    Thromb Res; 1981 Apr 1-15; 22(1-2):103-14. PubMed ID: 6457413
    [No Abstract]   [Full Text] [Related]  

  • 10. Catabolism of antithrombin III-protease complexes.
    Fuchs HE; Pizzo SV
    Thromb Res; 1983 Oct; 32(2):253-4. PubMed ID: 6658716
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro.
    Hatton MW; Moar SL
    Thromb Haemost; 1985 Apr; 53(2):228-34. PubMed ID: 4024034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of antithrombin III--thrombin complex. Formation of active and inactive antithrombin III.
    Griffith MJ; Lundblad RL
    Biochemistry; 1981 Jan; 20(1):105-10. PubMed ID: 7470462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of the thrombin time in cirrhosis.
    Braunstein KM; Kinard HB; Hepfer TW; Craig WR; Eurenius K
    Thromb Res; 1976 Oct; 9(4):301-17. PubMed ID: 136058
    [No Abstract]   [Full Text] [Related]  

  • 15. Affinity of antithrombin III for insoluble modified polystyrene.
    Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1987 Apr; 46(1):101-8. PubMed ID: 3590108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of molecular interaction by fluorescence polarization method].
    Mineno J
    Tanpakushitsu Kakusan Koso; 1997 Jan; 42(1):77-81. PubMed ID: 8990949
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
    Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
    Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.